HIV Diagnosis Market Growth Drivers, Trends, industry innovation demand analysis and Global Profit by 2028

The global HIV diagnosis market is likely to grow with a significant CAGR over the forecast period. The report offers a wide-ranging evaluation of demand, supply, and development scenarios by analysing the primary dynamics and segmental output of the industry. During the event prediction process, this study covers an accurate, serious investigation of the major players in the market and their structures. The study highlights the major profile of the organisation and its global market share, key strategies for growth, regional footprints, and top sales.

Click here to get sample of the premium report:

Scope of the Global HIV Diagnosis Market

This study has been prepared in order to offer a deep and basic view of the market to its end users. Some of the important aspects analysed in the report are production, consumption, revenue rate, key regions, market share, and major suppliers. The study views the performance of various regions and countries in the global HIV diagnosis market. The market size and share of all segments, geographies have been offered in the report. In addition, the study report discusses the pricing of goods, production methods and associated costs, as well as various related trends.

Rising worldwide HIV infection prevalence would significantly improve the market growth of HIV diagnostics over the forecast period. One of the leading causes of morbidity and mortality is HIV infection. According to the UNAIDS reports, there were more than 36.7 million people across the globe suffering from HIV in 2017. About 1.8 million children under 15 years of age have been infected with HIV. Furthermore, many were contaminated during pregnancy, childbirth or breast-feeding by their HIV-positive mothers. The increasing incidence of AIDS, especially in developing and underdeveloped economies, will offer a number of opportunities for growth in HIV diagnostics, leading to growth in the industry. In addition, improvement in HIV testing of blood products and donated blood to avoid the prevalence of HIV by blood transfusion has resulted in an increased number of blood transfusions and donations. In recent years, the use of diagnostic tests to test donated blood and blood products in compliance with set criteria to prevent the spread of diseases has increased.

Segment Analysis of the Global HIV Diagnosis Market

The global HIV diagnosis market has been segmented on the basis of test type, product, end user, and geographical region. Based on test type, the global HIV diagnosis market is segmented into Antibody, Viral Load, CD4 Count, Early Infant, and Viral Identification. Based on product, the global market is segmented into Assay, Kit, Reagent, Instrument, Software, and Services. By end user, this market segmented into Hospitals, Blood Banks, Home Care Settings, and Others.

Click here to get detailed premium report:

Geographical Analysis of the Global HIV Diagnosis Market

The report gives a thorough overview of the industry comprising qualitative and quantitative data. It offers detailed assessment and forecast of the global HIV diagnosis market based on different regional segments. This market majorly developed in the regions such as Asia Pacific, Europe, North America, and the Middle East and Africa. The U. S. HIV diagnostics market dominated the area of North America with a 77.7 percent revenue share in 2017, and due to the rising prevalence of HIV infection, it is expected to show a similar trend over the forecast period. Likewise, there were more than 1 million people infected with HIV in the U.S. in 2015, As per the data of Centers for Disease Control and Prevention (CDC).

Competitive Landscape of the Global HIV Diagnosis Market

The global HIV diagnosis market report comprises the profiles of leading companies along with their detailed SWOT analysis and several market strategies. Some of the key players in the global HIV diagnosis market include Siemens AG, Roche Danaher Corporation, Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Diagnostics, Abbott Laboratories, Dickinson & Company, Alere Inc., Bio-Rad Laboratories, and Hologic, Inc.

Market Segmentation:

By Test Type:

  • Antibody
    • ELISA
    • Rapid
    • Western Blot
  • Viral Load
  • CD4 Count
  • Early Infant
  • Viral Identification

By Product:

  • Assay
  • Kit
  • Reagent
  • Instrument
  • Software
  • Services

By End User:

  • Hospitals
  • Blood Banks
  • Home Care Settings
  • Other

By Region:

  • North America
    • North America, by Country
      • US
      • Canada
      • Mexico
    • North America, by Test Type
    • North America, by Product
    • North America, by End User
  • Western Europe
    • Western Europe, by Country
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • The Netherlands
      • Rest of Western Europe
    • Western Europe, by Test Type
    • Western Europe, by Product
    • Western Europe, by End User
  • Asia Pacific
    • Asia Pacific, by Country
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Indonesia
      • Rest of Asia Pacific
    • Asia Pacific, by Test Type
    • Asia Pacific, by Product
    • Asia Pacific, by End User
  • Eastern Europe
    • Eastern Europe, by Country
      • Russia
      • Turkey
      • Rest of Eastern Europe
    • Eastern Europe, by Test Type
    • Eastern Europe, by Product
    • Eastern Europe, by End User
  • Middle East
    • Middle East, by Country
      • UAE
      • Saudi Arabia
      • Qatar
      • Iran
      • Rest of Middle East
    • Middle East, by Test Type
    • Middle East, by Product
    • Middle East, by End User
  • Rest of the World
    • Rest of the World, by Country
      • South America
      • Africa
    • Rest of the World, by Test Type
    • Rest of the World, by Product
    • Rest of the World, by End User

Years Covered in the Study:

Historic Year: 2016-2017

Base Year: 2018

Estimated Year: 2019

Forecast Year: 2028

Objectives of this report:

  • To estimate market size for HIV diagnosis market on regional and global basis.
  • To identify major segments in HIV diagnosis market and evaluate theirmarket shares and demand.
  • To provide a competitive scenario for the HIV diagnosis market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of HIV diagnosis market with their potential gravity during the forecast period.


This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis




QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world’s most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.



Quince Market Insights

Office No- A109

Pune, Maharashtra 411028

Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 1444 39 0986

Email: [email protected]



Leave a comment

Your email address will not be published. Required fields are marked *